Page last updated: 2024-08-26

fulvestrant and 2,2'-azobis(2-amidinopropane)

fulvestrant has been researched along with 2,2'-azobis(2-amidinopropane) in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aschner, M; Feustel, PJ; Kimelberg, HK; Milatovic, D; Zhang, Y	1

Other Studies

1 other study(ies) available for fulvestrant and 2,2'-azobis(2-amidinopropane)

Article	Year
Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity. Experimental neurology, 2007, Volume: 204, Issue:2 Topics: Amidines; Analysis of Variance; Animals; Antioxidants; Disease Models, Animal; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Estradiol; Estrogen Antagonists; F2-Isoprostanes; Fulvestrant; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tamoxifen	2007

Article

Year

Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity.

Experimental neurology, 2007, Volume: 204, Issue:2

Topics: Amidines; Analysis of Variance; Animals; Antioxidants; Disease Models, Animal; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Estradiol; Estrogen Antagonists; F2-Isoprostanes; Fulvestrant; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tamoxifen

2007